Press Releases
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1.KEY INFORMATION (a)Full name of discloser:Dimensional Fund Advisors Ltd. whose parent is Dimensional Fund Advisors LP, and also on behalf their investment advisory affiliates (“Dimensional”). The Dimensional entities are investment advisors and Dimensional expressly disclaims beneficial... (continue reading...)FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1.KEY INFORMATION (a)Full name of discloser:Dimensional Fund Advisors Ltd. whose parent is Dimensional Fund Advisors LP, and also on behalf their investment advisory affiliates (“Dimensional”). The Dimensional entities are investment advisors and Dimensional expressly disclaims beneficial... (continue reading...)FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1.KEY INFORMATION (a)Full name of discloser:Dimensional Fund Advisors Ltd. whose parent is Dimensional Fund Advisors LP, and also on behalf their investment advisory affiliates (“Dimensional”). The Dimensional entities are investment advisors and Dimensional expressly disclaims beneficial... (continue reading...)CHARLOTTE, N.C., October 7, 2026 - ITDock, a modern IT documentation platform built for managed service providers and IT teams, announced an expansion of its platform with new deployment options and technician-focused workflow tools designed to make documentation easier to create, maintain and use... (continue reading...)
FORM 8.3
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDERRULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANTSECURITIES REPRESENTING 1% OR MORE
1.KEY INFORMATION (a)Full name of discloserDimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of... (continue reading...)More Press Releases
View Older Stories-
Dubai attracts 14,600 applications for 23 places on global talent programme
-
S&K Roofing Launches Instant Online Roofing Estimates for Northeast Ohio Homeowners
-
South Padre Island Vacation Rental Report 2027: Rising Lodging Revenue, Regional Investment and Road-Trip Value Point to Continued Demand
-
Result of the auction of 2.00 per cent DGB 2028 and 2.25 per cent DGB 2035
-
San Francisco Speeding Ticket Attorney Adam Cohen Explains Fines, DMV Points, and Defense Options for California Drivers
-
Chicago Divorce Attorney Michael Ian Bender Highlights Privacy Strategies for High-Profile Divorce
-
Hudson Valley DWI Defense Attorney Randall F. Inniss Guides Physicians Through Medical License Protection After a DWI Arrest
-
Ocean County Estate Planning Attorney Christine Matus Outlines Essential Estate Planning Tools for New Jersey Families
-
Boston Truck Accident Attorney Dino M. Colucci Outlines Liability and Federal Regulations in 18-Wheeler Collisions
-
TORM plc capital increase in connection with exercise of Restricted Share Units as part of TORM's incentive program
-
EGFR Non Small Cell Lung Cancer Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Astrazeneca, Bridge Biotherapeutics, Sichuan Kelun Pharma
-
Diabetic Foot Ulcers Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation – DelveInsight | Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience
-
Diabetic Retinopathy Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 – DelveInsight | Genentech, Ionis Pharma, AstraZeneca, Regenxbio, AbbVie, Palatin Tech
-
Deutsche Lufthansa AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
-
Inflammatory Bowel Disease Market Forecast 2036: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight | AbbVie, Janssen Pharma, Abivax, Morphic Therapeutic, Eli Lilly, Gilead
-
Degenerative Disc Disease Pipeline 2026: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight | Mesoblast, DiscGenics, Biosplice Therapeutics, BIOPHARM
-
Chronic Smell and Flavor Loss Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation – DelveInsight | Cyrano Therapeutics
-
Neuroblastoma Market Analysis 2034: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Y-mAbs Therapeutics, United Therapeutics Corp, EUSA Pharma, Clarity Pharma
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 06 10 2026] - (CGWL)
-
Krait Critical Minerals Appoints Dr. Thomas O'Rourke as Strategic Advisor
-
Liver Cancer Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight
-
Focal Segmental Glomerulosclerosis Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 – DelveInsight | Retrophin, AbbVie, AstraZeneca, Pfizer, Sanofi, Teva
-
Alpha Thalassemia Market Forecast 2036: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight | Forma Therapeutics, Genmedicon Biopharma, Bristol-Myers Squibb, Agios Pharma
-
Cerebral Palsy Market Analysis 2036: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Neurocrine Biosciences, Teva Pharma, Bundang CHA Hospital, Jazz Pharma
-
Beyond Now launches agentic platform to power CSPs growth in the agentic economy
-
Gemcorp and Fonds Souverain Malagasy Announce Strategic Partnership to Support Investment in Madagascar
-
Real machining challenges take centre stage for Dormer Pramet at AMB 2026
-
Securonix Named to 2026 Fortune Future 120 for Long-Term Growth Potential
-
United Nations Spotlight Initiative launches Sync or Storm, a new interactive game to help prevent violence against women and girls before it starts
-
Metastatic Prostate Cancer Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
-
Metastatic Breast Cancer Clinical Trial Drug Development Pipeline Expands with Contributions from 100+ Key Companies | DelveInsight
-
Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
-
Metastatic Colorectal Cancer Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 150+ Leading Players Wheeling the Therapeutics Landscape
-
Structural Heart Devices Market Insights and Competitive Analysis: Growth Drivers, Segment Trends, and Regional Outlook Through 2034
-
Metastatic Melanoma Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight
-
Idiopathic Membranous Nephropathy (IMN) Market Set to Grow from USD 130 Million in 2025 to USD 1,000 Million by 2036 as First Targeted Therapies AdvanceIdiopathic Membranous Nephropathy (IMN) Market
-
Neuropathic Pain Market Poised for Major Change Through 2032 as Pipeline Therapies AdvanceNeuropathic Pain Market
-
Non-Postoperative Pain Management Market is Projected to Grow by 2036 Owing to the Shift Toward Non-opioid Therapies and Advances in Rapid-Acting Pain Treatments | DelveInsight
-
What a Lincoln extended warranty does for your resale value when you sell privately
-
Psoriasis Market Outlook Through 2034: Growth Driven by Advances in Biologic and Oral Therapies
-
Complex Regional Pain Syndrome Market is Projected to Grow by 2036 Owing to Rising Chronic Pain Burden and Advances in Targeted Treatment Approaches | DelveInsight
-
Genome Editing Market to Grow at a CAGR of 13.19% Through 2032, Driven by Rising Genetic Disorders, Advancements in CRISPR Technologies, and Strategic Activities
-
Giant Cell Arteritis Market Set for Significant Growth Through 2034 Driven by Advancing Therapies, Rising Diagnosed Cases, and Expanding Treatment Landscape | DelveInsight
-
Rare NRG1 Fusion Market is Projected to Grow by 2034 Owing to the Advancement of Tumor-Agnostic Therapies and Precision Medicine | DelveInsight
-
Brain Cancer Market is Projected to Grow by 2036 Owing to the Emergence of Targeted Therapies and Novel Treatment Approaches | DelveInsight
-
Retinopathy of Prematurity Market is Projected to Grow by 2036 Owing to the Increasing Adoption of Anti-VEGF Therapies and Emerging Treatment Approaches | DelveInsight
-
Osteoporosis Market to Witness Significant Growth Through 2036 Driven by Emerging Therapies, Expanding Treatment Landscape, and Rising Disease Burden | DelveInsight
-
Knee Osteoarthritis Market is Projected to Grow by 2036 Owing to the Rising Disease Burden and Advancement of Regenerative and Disease-Modifying Therapies | DelveInsight
-
Devexperts Appoints Rainer Fuchsluger as Global Group CEO to Accelerate International Growth and Advance its FinTech Portfolio
-
Atlassian Launches Forward Deployed Engineering Program to Scale Enterprise AI Transformation


